Lexicon Pharmaceuticals (NASDAQ:LXRX) expects two key milestones in the first quarter of 2027: results from a pivotal heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results